{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:56:08Z","timestamp":1789916168434,"version":"4.0.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143837","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T18:48:36Z","timestamp":1455043716000},"page":"e0143837","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hospital Admissions, Transfers and Costs of Guillain-Barr\u00e9 Syndrome"],"prefix":"10.1371","volume":"11","author":[{"given":"Nikki","family":"van Leeuwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester F.","family":"Lingsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Vanrolleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C. J. M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewout W.","family":"Steyerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"issue":"9497","key":"ref1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guilain-Barre syndrome","volume":"366","author":"RA Hughes","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 2","key":"ref2","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barre syndrome","volume":"176","author":"RA Hughes","year":"1997","journal-title":"J Infect Dis"},{"issue":"17","key":"ref3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"FG Van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"issue":"Pt 9","key":"ref4","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"RA Hughes","year":"2007","journal-title":"Brain"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/WNL.56.4.564","article-title":"Changes in referral pattern and its effect on outcome in patients with Guillain-Barr\u00e9 syndrome","volume":"56","author":"R Van Koningsveld","year":"2001","journal-title":"Neurolgy"},{"issue":"Pt 1","key":"ref6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"C Fokke","year":"2014","journal-title":"Brain"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Dutch GBS Study Group. Pain in Guillain-Barr\u00e9 syndrome: a long-term follow-up study","volume":"75","author":"L Ruts","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.0b013e31820e7b62","article-title":"Recognizing Guillain-Barre syndrome in preschool children","volume":"76","author":"J Roodbol","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.wnl.0000167549.09664.b8","article-title":"Distinguishing acute-onset CIDP from Guillain-Barr\u00e9 syndrome with treatment related fluctuations","volume":"65","author":"L Ruts","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1186\/cc11662","article-title":"Effect of non-clinical inter-hospital critical care unit to unit transfer of critically ill patients: a propensity-matched cohort analysis","volume":"16","author":"H Barrat","year":"2012","journal-title":"Crit Care"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"R446","DOI":"10.1186\/cc3749","article-title":"Quality of interhospital transport of critically ill patients: a prospective audit","volume":"9","author":"JJ Ligtenberg","year":"2005","journal-title":"Crit Care"},{"issue":"343","key":"ref12","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe","volume":"12","author":"JP Dieleman","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis and presentation of immunization safety data","volume":"29","author":"JJ Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"ref14","unstructured":"STZ [homepage on the Internet]. Bureau Samenwerkende Topklinische opleidingsZiekenhuizen; [cited 5 February 2013]. Avaiable from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.stz.nl\/\" xlink:type=\"simple\">http:\/\/www.stz.nl\/<\/ext-link>"},{"key":"ref15","unstructured":"Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg [homepage on the Internet]. College voor zorgverzekeringen; [updated January 2010.; cited 5 February 2013]. Avaiable from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cvz.nl\/binaries\/live\/cvzinternet\/hst_content\/nl\/documenten\/losse-publicaties\/handleiding-kostenonderzoek-2010.pdf\" xlink:type=\"simple\">http:\/\/www.cvz.nl\/binaries\/live\/cvzinternet\/hst_content\/nl\/documenten\/losse-publicaties\/handleiding-kostenonderzoek-2010.pdf<\/ext-link>"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1212\/01.wnl.0000316393.54258.d1","article-title":"Economic cost of Guillain-Barr\u00e9 syndrome in the United States","volume":"71","author":"PD Frenzen","year":"2008","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1472-6963-11-101","article-title":"Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barr\u00e9 syndrome","volume":"11","author":"JL Winters","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"ref18","first-page":"459","article-title":"Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome","volume":"49","author":"MM Mehndiratta","year":"2001","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<107::AID-JCA1>3.0.CO;2-3","article-title":"Treatment of Guillain-Barr\u00e9 syndrome: a cost-effectiveness analysis","volume":"14","author":"S Nagpal","year":"1999","journal-title":"J Clin Apher"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1017\/S0950268800004933","article-title":"Health burden in the Netherlands due to infection with thermophilic Campylobacter","volume":"125","author":"AH Havelaar","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barr\u00e9 syndrome","volume":"76","author":"C Walgaard","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome","volume":"67","author":"C Walgaard","year":"2010","journal-title":"Ann Neurol"},{"issue":"42","key":"ref23","first-page":"A3808","article-title":"Imminent respiratory insufficiency in childeren resulting from Guillain-Barr\u00e9 syndrome","volume":"155","author":"MC De Wit","year":"2011","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:06:01Z","timestamp":1718352361000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143837"}},"subtitle":[],"editor":[{"given":"Ralf Andreas","family":"Linker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143837","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]}}}